{"SPADE_UN_17118": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17118", "Peptide Name": "PF14", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "AGYLLGKLLOOLAAAALOOLL", "Sequence Length": 21, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Stearylation", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C82H134N18O15", "Mass": 196904, "PI": 9.3, "Net Charge": 1, "Hydrophobicity": 1.591, "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions.", "Pubmed ID": "22698942", "Reference": "J Control Release. 2012 Aug 20;162(1)1-8.", "Author": "Ezzat K, Zaghloul EM, El Andaloussi S, Lehto T, El-Sayed R, Magdy T, Smith CI, Langel U.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=22698942"}], "Frequent Amino Acids": "LAO", "Absent Amino Acids": "CDEFHIMNPQRSTUVW", "Basic Residues": 1, "Acidic Residues": 0, "Hydrophobic Residues": 14, "Polar Residues": 7, "Positive Residues": 1, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_05236", "Similarity": 1.0, "Sequence": "MELVVWKDGDNWRVFADDAVPALDGTVDRVAEGLATLYRKEKEPVVFTRRKTAFYDGQYWLMWKYYPTYGRAYGKEASDEMIKEPSAIALLAGY"}, {"SPADE_ID": "SPADE_UN_17157", "Similarity": 1.0, "Sequence": "AGYLLGLLLAAAALLL"}, {"SPADE_ID": "SPADE_UN_00472", "Similarity": 1.0, "Sequence": "ALLLAIRKR"}]}}}